MUMBAI, India, Oct. 12 -- Intellectual Property India has published a patent application (202617073042 A) filed by Rhythm Pharmaceuticals, Inc. on June 12, 2026, for Combinations Of A Potassium Channel Activator And An Mc4r Agonist And Related Methods Of Use.

Inventors include Grujic, Danica; Meeker, David, Pell; Wigerinck, Piet; Van Der Sande, Claudine; and Garfield, Alastair.

The application for the patent was published on October 09, 2026, under issue no. 41/2026.

Abstract: The disclosure relates to a method of treating a disease or disorder in a subject using a combination of: (i) a potassium channel activator (e.g., a SURx/Kirx channel activator compound) or a pharmaceutically acceptable salt thereof; and (ii) a melanocortin-4 recep...